isoniazid has been researched along with antipyrine in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (60.71) | 18.7374 |
1990's | 3 (10.71) | 18.2507 |
2000's | 3 (10.71) | 29.6817 |
2010's | 5 (17.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Adjepon-Yamoah, KK; Finlayson, ND; Forrest, JA; Prescott, LF | 1 |
Dhumeaux, D; Mavier, P; Miguet, JP; Soussy, CJ | 1 |
Reidenberg, MM | 1 |
Beliakova, GA; Blinkov, IL; Fedorov, EA; Kukes, VG; Starodubtsev, AK | 1 |
Jenkins, MV; Perry, W | 2 |
Vesell, ES | 3 |
Cohn, VH; Sieber, SM; Wynn, WT | 1 |
Waser, PG | 1 |
Mehta, S | 1 |
Abernethy, DR; Greenblatt, DJ; Knüchel, M; Ochs, HR; Verburg-Ochs, B | 1 |
Abeyasekera, G; Boobis, AR; Brodie, MJ; Hillyard, CJ; MacIntyre, I; Park, BK; Stevenson, JC | 1 |
Abeyasekera, G; Boobis, AR; Brodie, MJ; Hillyard, CJ; MacIntyre, I; Park, BK | 1 |
Chailleux, E; Kergueris, MF; Larousse, C; Le Normand, Y; Moigneteau, C; Ordronneau, J; Veyrac, MJ | 1 |
Larousse, C | 1 |
Kolpakov, AR; Kolpakov, MA; Panin, LE | 1 |
Grek, OR; Kolpakov, MA; Sharapov, VI | 1 |
Batzias, J; Horbach, GJ; Maas, RF; van Miert, AS; Witkamp, RF; Zweers-Zeilmaker, WM | 1 |
Enikeev, DA; Kamilov, EKh; Kravetz, ED; Sabitova, R; Samsonov, VM; Shakirov, DF | 1 |
5 review(s) available for isoniazid and antipyrine
Article | Year |
---|---|
Drug metabolism in liver disease.
Topics: Acetaminophen; Acute Disease; Antipyrine; Chemical and Drug Induced Liver Injury; Chronic Disease; Half-Life; Humans; Isoniazid; Lidocaine; Liver; Liver Diseases; Pharmaceutical Preparations; Tolbutamide | 1975 |
Polygenic factors controlling drug response.
Topics: Adult; Animals; Antipyrine; Caffeine; Dicumarol; Environment; Ethanol; Female; Genetic Variation; Half-Life; Halothane; Humans; Isoniazid; Male; Metabolic Clearance Rate; Mice; Middle Aged; Nortriptyline; Pharmaceutical Preparations; Phenylbutazone; Pregnancy; Smoking; Twins | 1974 |
Recent progress in pharmacogenetics.
Topics: Adult; Aged; Alcohol Oxidoreductases; Antipyrine; Asian People; Child, Preschool; Cholinesterases; Cyanides; Dicumarol; Diseases in Twins; Drug Hypersensitivity; Erythrocytes; Favism; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Isoniazid; Liver; Male; Metabolism, Inborn Errors; Middle Aged; Pharmacogenetics; Phenylbutazone; Phenylthiourea; Phenytoin; Pregnancy; Primaquine; Twins; Warfarin | 1969 |
Recent progress in pharmacogenetics.
Topics: Adult; Antipyrine; Cyanides; Dicumarol; Erythrocytes; Ethnicity; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Isoniazid; Male; Middle Aged; Mutation; Pharmacogenetics; Phenylbutazone; Phenylthiourea; Phenytoin; Pregnancy; Racial Groups; Taste; Twins | 1969 |
Drug disposition in children with protein energy malnutrition.
Topics: Acetaminophen; Antipyrine; Biological Availability; Biotransformation; Child; Child, Preschool; Chloramphenicol; Gentamicins; Humans; Infant; Isoniazid; Kidney; Liver; Penicillins; Pharmaceutical Preparations; Protein-Energy Malnutrition; Sulfadiazine; Tissue Distribution | 1983 |
23 other study(ies) available for isoniazid and antipyrine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
Topics: Adult; Antipyrine; Drug Interactions; Enzyme Induction; Female; Half-Life; Humans; Isoniazid; Liver; Male; Microsomes, Liver; Middle Aged; Oxidation-Reduction; Oxidoreductases; Rifampin | 1977 |
Obesity and fasting--effects on drug metabolism and drug action in man.
Topics: Adult; Animals; Antipyrine; Atropine; Blood Proteins; Fasting; Female; Humans; Isoniazid; Obesity; Pharmaceutical Preparations; Procaine; Protein Binding; Sulfisoxazole; Tolbutamide | 1977 |
[Pharmacological testing of the system of biotransformation of xenobiotics].
Topics: Acetylation; Antipyrine; Biotransformation; Humans; Isoniazid; Liver; Oxidation-Reduction; Phenotype | 1988 |
Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
Topics: Antipyrine; Diet, Vegetarian; Drug Therapy, Combination; Enzyme Induction; Female; Half-Life; Humans; Hydrocortisone; India; Isoniazid; Liver; Male; Mixed Function Oxygenases; Quinine; Rifampin; Streptomycin; Tuberculosis | 1986 |
Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
Topics: Antipyrine; Enzyme Induction; Female; Glucaric Acid; Glucuronidase; Half-Life; Humans; Isoniazid; Liver; Male; Mixed Function Oxygenases; Rifampin; Streptomycin; Sugar Acids; Time Factors | 1986 |
The entry of foreign compounds into the thoracic duct lymph of the rat.
Topics: Acids; Alcohols; Amines; Aniline Compounds; Animals; Anthracenes; Antipyrine; Benzoates; Caffeine; Carbon Radioisotopes; Chromatography, Paper; Chromatography, Thin Layer; Chylomicrons; DDT; Digoxin; Estradiol; Isoniazid; Lymph; Male; Phenanthrenes; Salicylates; Testosterone; Thoracic Duct; Time Factors; Tritium | 1974 |
[Pharmacogenetics].
Topics: Anemia, Hemolytic; Antipyrine; DNA; Drug-Related Side Effects and Adverse Reactions; Europe; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Humans; Isoniazid; Pharmacogenetics; Phenacetin; Polyneuropathies; Primaquine; Quinine; Racial Groups; Sulfonamides | 1967 |
Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
Topics: Acetaminophen; Adult; Antipyrine; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Interactions; Female; Half-Life; Humans; Isoniazid; Liver; Male; Oxidation-Reduction | 1984 |
Effect of rifampicin and isoniazid on vitamin D metabolism.
Topics: Adult; Aged; Antipyrine; Calcium; Drug Interactions; Female; Humans; Isoniazid; Kinetics; Male; Middle Aged; Parathyroid Hormone; Rifampin; Tuberculosis, Pulmonary; Vitamin D | 1982 |
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.
Topics: Acetylation; Adult; Antipyrine; Calcium; Humans; Isoniazid; Kidney; Liver; Male; Mixed Function Oxygenases; Oxygenases; Parathyroid Hormone; Phenotype; Phosphates; Rifampin; Tuberculosis, Pulmonary; Vitamin D | 1981 |
Tuberculosis therapy and enzyme induction in man.
Topics: Acetylation; Adult; Aged; Antipyrine; Antitubercular Agents; Enzyme Induction; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1980 |
Rifampicin.
Topics: Animals; Antipyrine; Enzyme Induction; Humans; Isoniazid; Rifampin | 1980 |
[Pharmacokinetics of antipyrine and isoniazid in rats during dynamics of cold adaptation].
Topics: Adaptation, Physiological; Animals; Antipyrine; Arylamine N-Acetyltransferase; Biotransformation; Cold Temperature; Cytochrome P-450 Enzyme System; Isoniazid; Liver; Male; Rats; Rats, Wistar | 1994 |
[The effect of acute hypoxia on antipyrine and isoniazid pharmacokinetics in rats with different resistances to oxygen deficiency].
Topics: Acute Disease; Animals; Antipyrine; Atmosphere Exposure Chambers; Disease Susceptibility; Half-Life; Hypoxia; Isoniazid; Male; Rats; Rats, Wistar; Time Factors | 1993 |
In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers.
Topics: Animals; Antipyrine; beta-Naphthoflavone; Biotransformation; Blotting, Western; Caffeine; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Goats; Isoniazid; Microsomes, Liver; Phenobarbital; Sulfamethazine; Troleandomycin | 1996 |
[THE BIOCHEMICAL AND PATHOPHYSIOLOGICAL MARKERS OF CHEMICAL EFFECT ON ORGANISM, THEIR INFORMATIVENESS AND DIAGNOSTIC SIGNIFICANCE].
Topics: Adult; Antipyrine; Biomarkers; Catalase; Chemical Industry; Erythrocytes; Female; Glutathione; Glyceraldehyde-3-Phosphate Dehydrogenases; Hexokinase; Humans; Hydrocarbons, Aromatic; Isoniazid; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Peroxidase; Pyruvate Kinase; Saliva; Sodium-Potassium-Exchanging ATPase; Sulfhydryl Compounds; Superoxide Dismutase | 2016 |